These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 22228721)
21. Drug Policy and the Public Good: a summary of the book. Drugs and Public Policy Group Addiction; 2010 Jul; 105(7):1137-45. PubMed ID: 20642498 [TBL] [Abstract][Full Text] [Related]
22. Social policy issues in narcotics abuse. Schmolling P J Health Soc Policy; 1993; 5(2):49-65. PubMed ID: 10171762 [TBL] [Abstract][Full Text] [Related]
23. A national drug agency. West R; Borden EK; Collet JP; Rawson NS; Tonks RS CMAJ; 2003 Apr; 168(8):962-3. PubMed ID: 12695372 [No Abstract] [Full Text] [Related]
24. Projections for the future development of international drug control policies. Oppenheimer TM Bull Narc; 1990; 42(1):3-14. PubMed ID: 2095934 [TBL] [Abstract][Full Text] [Related]
25. Prescription-drug prices. Frank RG N Engl J Med; 2004 Sep; 351(14):1375-7. PubMed ID: 15459294 [No Abstract] [Full Text] [Related]
26. Harm reduction is now the mainstream global drug policy. Wodak A Addiction; 2009 Mar; 104(3):343-5; discussion 345-6. PubMed ID: 19207340 [No Abstract] [Full Text] [Related]
27. Public policy statement on national drug policy. American Society of Addiction Medicine. J Addict Dis; 1994; 13(4):231-4. PubMed ID: 7734471 [No Abstract] [Full Text] [Related]
28. Multi-level governance: The way forward for European illicit drug policy? Chatwin C Int J Drug Policy; 2007 Dec; 18(6):494-502. PubMed ID: 18061875 [TBL] [Abstract][Full Text] [Related]
29. Legitimacy and modernity via policy transfer: the utility of the 2003 Afghan National Drug Control Strategy. Bewley-Taylor DR Int J Drug Policy; 2014 Sep; 25(5):1009-18. PubMed ID: 24835270 [TBL] [Abstract][Full Text] [Related]
30. Supply reduction's hidden casualties: a view from the trenches. Strathdee SA; Patterson TL Addiction; 2009 Mar; 104(3):340-1; discussion 345-6. PubMed ID: 19207337 [No Abstract] [Full Text] [Related]
32. Normalization and harm reduction: research avenues and policy agendas. Erickson PG; Hathaway AD Int J Drug Policy; 2010 Mar; 21(2):137-9. PubMed ID: 20022234 [TBL] [Abstract][Full Text] [Related]
33. [Basic principles and justification of drug policy]. Weinacht PL Gesundheitswesen; 1999 Oct; 61(10):455-63. PubMed ID: 10593048 [TBL] [Abstract][Full Text] [Related]
34. Harm reduction and illegal drugs: the real debate. Mangham C Can J Public Health; 2001; 92(3):204-5. PubMed ID: 11496631 [No Abstract] [Full Text] [Related]
35. Cannabis policy: issues and options. Abel S; Casswell S N Z Med J; 1998 Sep; 111(1074):367-70. PubMed ID: 11039824 [TBL] [Abstract][Full Text] [Related]
36. The role of drug and alcohol policy in reducing Indigenous over-representation in prison. Weatherburn DJ Drug Alcohol Rev; 2008 Jan; 27(1):91-4. PubMed ID: 18034386 [TBL] [Abstract][Full Text] [Related]
38. Assessing alternative drug control regimes. MacCoun R; Reuter P; Schelling T J Policy Anal Manage; 1996; 15(3):330-52. PubMed ID: 10848158 [TBL] [Abstract][Full Text] [Related]
39. Harm reduction, HIV/AIDS, and the human rights challenge to global drug control policy. Elliott R; Csete J; Wood E; Kerr T Health Hum Rights; 2005; 8(2):104-38. PubMed ID: 17136905 [TBL] [Abstract][Full Text] [Related]
40. The physician as a servant of public policy. Stimmel B Mt Sinai J Med; 1991 Oct; 58(5):433-6; discussion 437-42. PubMed ID: 1753983 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]